➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Medtronic
Johnson and Johnson
AstraZeneca
Dow

Last Updated: April 18, 2021

DrugPatentWatch Database Preview

FELODIPINE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Felodipine, and what generic alternatives are available?

Felodipine is a drug marketed by Aurobindo Pharma Ltd, Glenmark Generics, Heritage Pharms Inc, Jubilant Generics, Mylan, Orchid Hlthcare, Sun Pharm Inds Ltd, Sun Pharm Industries, Torrent Pharms Ltd, Vintage Pharms Llc, Wockhardt Ltd, Yiling, and Yung Shin Pharm. and is included in thirteen NDAs.

The generic ingredient in FELODIPINE is felodipine. There are seventeen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the felodipine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Felodipine

A generic version of FELODIPINE was approved as felodipine by SUN PHARM INDUSTRIES on November 2nd, 2004.

  Start Trial

Drug patent expirations by year for FELODIPINE
Drug Prices for FELODIPINE

See drug prices for FELODIPINE

Drug Sales Revenue Trends for FELODIPINE

See drug sales revenues for FELODIPINE

Recent Clinical Trials for FELODIPINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rigshospitalet, DenmarkPhase 4
Lawson Health Research InstitutePhase 1
Lee's Pharmaceutical LimitedPhase 4

See all FELODIPINE clinical trials

Pharmacology for FELODIPINE
Medical Subject Heading (MeSH) Categories for FELODIPINE
Paragraph IV (Patent) Challenges for FELODIPINE
Tradename Dosage Ingredient NDA Submissiondate
PLENDIL TABLET, EXTENDED RELEASE;ORAL felodipine 019834

US Patents and Regulatory Information for FELODIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt Ltd FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 091484-002 Aug 15, 2012 DISCN No No   Start Trial   Start Trial   Start Trial
Vintage Pharms Llc FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 200815-001 Oct 28, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Wockhardt Ltd FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 091484-003 Aug 15, 2012 DISCN No No   Start Trial   Start Trial   Start Trial
Vintage Pharms Llc FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 200815-002 Oct 28, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
McKesson
Merck
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.